Preclinical Studies in Anti-<i>Trypanosomatidae</i> Drug Development

Preclinical Studies in Anti-<i>Trypanosomatidae</i> Drug Development

The trypanosomatid parasites <i>Trypanosoma brucei</i>, <i>Trypanosoma cruzi</i> and <i>Leishmania</i> are the causative agents of human African trypanosomiasis, Chagas Disease and Leishmaniasis, respectively. These infections primarily affect poor, rural communit...

Full description

Bibliographic Details
Main Authors: Cintya Perdomo, Elena Aguilera, Ileana Corvo, Paula Faral-Tello, Elva Serna, Carlos Robello, Shane R. Wilkinson, Gloria Yaluff, Guzmán Alvarez
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Pharmaceuticals
Subjects:
anti-trypanosomatid
arylidene ketones
thiazolidene hydrazines
Pathogen box
veterinary isolates
Online Access:https://www.mdpi.com/1424-8247/14/7/644

Internet

https://www.mdpi.com/1424-8247/14/7/644

Similar Items